Codiakbio
About Codiakbio
Codiak BioSciences Inc is developing exosome-based therapeutics using its engEx Platform to create engineered exosomes for the treatment of diseases with high unmet medical needs, including oncology and neuromuscular disorders. The company aims to provide targeted delivery of therapeutic agents, improving treatment efficacy and patient outcomes in complex disease areas.
Codiak BioSciences Inc is developing exosome-based therapeutics using its engEx Platform to create engineered exosomes for the treatment of diseases with high unmet medical needs, including oncology and neuromuscular disorders. The company aims to provide targeted delivery of therapeutic agents, improving treatment efficacy and patient outcomes in complex disease areas.
What does Codiakbio do?
Codiak BioSciences Inc is developing exosome-based therapeutics using its engEx Platform to create engineered exosomes for the treatment of diseases with high unmet medical needs, including oncology and neuromuscular disorders. The company aims to provide targeted delivery of therapeutic agents, improving treatment efficacy and patient outcomes in complex disease areas.
Where is Codiakbio located?
Codiakbio is based in Cambridge, United Kingdom.
- Location
- Cambridge, United Kingdom 0
- Investors
- Ecor1Cap
